Massachusetts General Hospital Cox Bldg Room 640 — Boston, Massachusetts

Massachusetts General Hospital Cox Bldg Room 640 is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital Cox Bldg Room 640 has participated in 1 clinical trials.

Therapeutic areas: Acute Myelogenous Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Graft vs. Host Disease (GvHD).

Sponsors: Genzyme, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital Cox Bldg Room 640?

Massachusetts General Hospital Cox Bldg Room 640 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital Cox Bldg Room 640 conducted?

Massachusetts General Hospital Cox Bldg Room 640 has 1 clinical trials on record. Their work covers Acute Myelogenous Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Graft vs. Host Disease (GvHD).

Is Massachusetts General Hospital Cox Bldg Room 640 accredited by Crixeo Health?

Massachusetts General Hospital Cox Bldg Room 640 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital Cox Bldg Room 640?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.